Learn More About Intradigm’s Broad RNAi Therapeutic Platform |
 |
 |
|
|
For more information on the merger between Silence Therapeutics and Intradigm, completed on Jan 5, 2010: |
| |
|
|
|
Jan 5 2010
Silence Therapeutics Announces Completion of Merger with Intradigm Corporation and Issue of New Shares
Dec 16 2009
Silence Therapeutics to Merge with Intradigm Corp to Create Leading RNAi Therapeutics Company
Mar 17 2009
Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence |
